Sanofi (SNYNF) EPS (Basic) (2009 - 2026)

Sanofi has disclosed EPS (Basic) across 18 years of filings, most recently posting $21.59 for Q1 2026.

• EPS (Basic) for Q1 2026 came in at $21.59, down 84.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $768.86 (up 312.63% YoY), and the FY2025 annual result was $7.45, up 57.02% from the prior year.
• EPS (Basic) came in at $21.59 for Q1 2026 at Sanofi, up from -$1.18 in the prior quarter.
• In the past five years, EPS (Basic) ranged from a high of $851.09 in Q2 2023 to a low of -$1.18 in Q4 2025.
• The 5-year median for EPS (Basic) is $11.62 (2022), against an average of $159.2.
• Across the five-year window, EPS (Basic) jumped 8037.92% in 2024 and plunged 726.69% in 2025, its largest moves.
• Sanofi's EPS (Basic) stood at $5.23 in 2022, then tumbled by 106.7% to -$0.35 in 2023, then surged by 59.44% to -$0.14 in 2024, then slumped by 726.69% to -$1.18 in 2025, then jumped by 1936.15% to $21.59 in 2026.
• The last three EPS (Basic) figures came in at $21.59 (Q1 2026), -$1.18 (Q4 2025), and $607.43 (Q3 2025), per Business Quant data.